Tokushima University / Educator and Researcher Directory --- Minato, Saki

Search:

Tokushima University ⟩ University Hospital ⟩ Central Clinical Facilities ⟩ ゲノム医療センター ⟩
Tokushima University ⟩ University Hospital ⟩ Clinical Division ⟩ Department of Pediatrics,Obstetrics and Gynecology ⟩ Obstetrics snd Gynecology ⟩

(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

Subject of Study

Book / Paper

Book:

1.	Takeshi Iwasa, Asuka Takeda and Saki Minato : わが国におけるPGTの流れ, メディカルドゥ, Jan. 2024.
2.	Takeshi Iwasa and Saki Minato : 乳漏性無月経・高プロラクチン血症, Nankodo, Dec. 2021.
3.	Takeshi Iwasa, Saki Minato and Yuri Yamamoto : 多嚢胞性卵巣症候群(PCOS), 総合医学社, Sep. 2021.

Academic Paper (Judged Full Paper):

1.	Hiroki Noguchi, ARATA Moeka, Saki Minato, Kou Tamura, AOKI Hidenori, Asuka Takeda, Yuri Yamamoto, 平田寛之, Takeshi Iwasa and Toshiya Matsuzaki : 多囊胞性卵巣症候群の診断におけるアクセス試薬を用いた血中LH基礎値及びLH/FSH比のカットオフ値の設定と内分泌異常の発現率に関する検討, Japanese Journal of Medicine and Pharmaceutical Science, Vol.82, No.3, 2025.
2.	Hiroki Noguchi, Akira Iwase, Takeshi Iwasa, Haruhiko Kanasaki, Fuminori Kimura, Koji Kugu, Kazuki Saito, Tsuyoshi Baba, Tetsuaki Hara, Saki Minato, Rie Yanagihara and Toshiya Matsuzaki : Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria, The Journal of Obstetrics and Gynaecology Research, Vol.51, No.1, e16152, 2025. (Summary) Japanese patients with polycystic ovary syndrome (PCOS) exhibit distinct body type characteristics, such that the rate of overweight/obese women is remarkably low. In addition, hyperandrogenism is relatively rare among Japanese PCOS patients. Therefore, these factors are considered in PCOS diagnostic criteria used in Japan. Diagnostic criteria for PCOS were recently revised by the Japan Society of Obstetrics and Gynecology based on a nationwide survey of PCOS and released on December 5, 2023 (JSOG2024). JSOG2024 criteria diagnosed PCOS according to the following three items: (1) irregular menstrual cycle/chronic anovulation, (2) polycystic ovarian morphology or elevated serum anti-Müllerian hormone (AMH) level, and (3) hyperandrogenism or high luteinizing hormone. The presence of all three items is required to diagnose PCOS, after excluding other diseases with symptoms similar to PCOS. We also established AMH cut-off values by age and a system for evaluating ovarian findings useful for both the JSOG2024 and Rotterdam criteria. We anticipate that the JSOG2024 criteria with cut-off values will enhance the treatment of Japanese patients with PCOS and those of other ethnicities with low obesity and hirsutism. (Keyword) diagnostic criteria / JSOG2024 / polycystic ovary syndrome (Link to Publication Site) ● Publication site (DOI): 10.1111/jog.16152 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 39569644 ● Summary page in Scopus @ Elsevier: 2-s2.0-85210095172 (DOI: 10.1111/jog.16152, PubMed: 39569644, Elsevier: Scopus)
3.	Takashi Kaji, 荒田萌花, Kou Tamura, AOKI Hidenori, Hiroki Noguchi, 矢野祐也, 林倫子, 大和田陽菜, TAKAHASHI Ayana, Asuka Takeda, Saki Minato, 谷口友香, Atsuko Yoshida, Ayuka Mineda, Riyo Kinouchi, Kanako Yoshida, Takeshi Iwasa and Yuri Yamamoto : 生殖補助医療におけるLH濃度低値の症例に対するFSH単剤使用の臨床成績, 徳島産婦人科医報, Vol.57, 23-27, 2024.
4.	Arata Moeka, Kou Tamura, Aoki Hidenori, Hiroki Noguchi, Asuka Takeda, Saki Minato, Yamamoto Shota, Riyo Kinouchi, Kanako Yoshida, Yuri Yamamoto, Takashi Kaji and Takeshi Iwasa : The effects of testosterone on hypothalamic and serum oxytocin levels are affected by the estrogen milieu in female rats, Nutrients, Vol.16, No.15, 2533, 2024. (Link to Publication Site) ● Publication site (DOI): 10.3390/nu16152533 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85200833092 (DOI: 10.3390/nu16152533, Elsevier: Scopus)
5.	Rie Masaki, Yuri Yamamoto, Kou Tamura, Hidenori Aoki, Hiroki Noguchi, Asuka Takeda, Saki Minato, Risa Tanano, Erika Yamanaka, Takaaki Maeda, Tatsuo Sugimoto, Hikari Sasada, Hiroaki Inui, Tomohiro Kagawa, Atsuko Yoshida, Ayuka Mineda, Riyo Kinouchi, Kanako Yoshida, Takashi Kaji and Takeshi Iwasa : Comparison of endogenous hypothalamic and serum OT levels between young and middle-aged perimenopausal female rats, The Journal of Medical Investigation : JMI, Vol.71, No.3.4, 246-250, 2024. (Summary) Oxytocin (OT) regulates food intake and body weight, particularly in obese individuals. Decreases in the effects of OT have recently been implicated in metabolic disturbances, and the administration of estradiol (E2) increased serum OT levels. Although weight gain is frequently observed in perimenopausal women, endogenous OT levels remain unclear. Therefore, we herein compared endogenous levels of hypothalamic and serum OT between young and middle-aged perimenopausal female rats and examined the relationship between serum estrogen and leptin levels. Body weight and visceral and subcutaneous fat weights were higher in middle-aged rats. Although no significant differences were observed in serum OT and E2 levels, serum leptin levels and hypothalamic mRNA levels of OT and the OT receptor (OTR) were significantly higher in middle-aged rats than in young rats. Serum OT levels did not correlate with hypothalamic OT mRNA levels or serum E2 levels. E2 maintains serum OT levels in perimenopausal rats, and other factors may elevate hypothalamic OT/OTR mRNA levels. Increases in body and fat weights in perimenopausal rats may be attributed to factors other than OT. Therefore, the administration of OT alone may not be sufficient to prevent metabolic disorders induced by the perimenopausal status. J. Med. Invest. 71 : 246-250, August, 2024. (Keyword) Animals / Female / Hypothalamus / Oxytocin / Rats / Leptin / Perimenopause / Estradiol / RNA, Messenger / Body Weight / Rats, Sprague-Dawley / Receptors, Oxytocin (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.71.246 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 39462559 ● Search Scopus @ Elsevier (PMID): 39462559 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.71.246 (DOI: 10.2152/jmi.71.246, PubMed: 39462559)
6.	Shuhei Kamada, Hiroki Noguchi, Shota Yamamoto, Kou Tamura, Hidenori Aoki, Asuka Takeda, Maimi Uchishiba, Saki Minato, Moeka Arata, Ryosuke Arakaki, Hiroaki Inui, Tomohiro Kagawa, Takako Kawakita, Atsuko Yoshida, Ayuka Mineda, Yuri Yamamoto, Riyo Kinouchi, Kanako Yoshida, Takashi Kaji, Masato Nishimura and Takeshi Iwasa : Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats, Brain, Behavior, & Immunity - Health, Vol.38, 100772, 2024. (Summary) Polycystic ovary syndrome (PCOS) is associated with an increased risk of psychological distress as well as enhanced responses to psychosocial stress. Recently, it was hypothesized that PCOS patients may be at high risk of novel COVID-19 infections and worse clinical presentations during such infections. Here, we evaluated the effects of PCOS on stress responses to bacterial and viral mimetics using dihydrotestosterone-induced PCOS model rats. Lipopolysaccharide (LPS; a bacterial mimetic) or polyinosinic-polycytidylic acid (Poly-IC; a viral mimetic) was injected into PCOS model rats (PCOS) and non-PCOS rats (control), and the rats' stress responses were evaluated. In the PCOS group, the rats' anorectic and febrile responses to LPS injection were enhanced, whereas their anorectic and febrile responses to Poly-IC injection were unaltered. The PCOS group also exhibited greater changes in peripheral cytokine levels in response to LPS, but not Poly-IC. On the contrary, after the injection of Poly-IC depressed locomotor activity was more evident in the PCOS group, whereas no such changes were observed after LPS injection. These findings indicate that although the stress responses of PCOS model rats to infection may be enhanced, the patterns of change in stress responses and their underlying mechanisms may differ between bacterial and viral infections. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.bbih.2024.100772 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38650845 ● Search Scopus @ Elsevier (PMID): 38650845 ● Search Scopus @ Elsevier (DOI): 10.1016/j.bbih.2024.100772 (DOI: 10.1016/j.bbih.2024.100772, PubMed: 38650845)
7.	Asuka Takeda, Yuri Yamamoto, Kou Tamura, Hidenori Aoki, Hiroki Noguchi, Saki Minato, Shuhei Kamada, Ryosuke Arakaki, Takashi Kaji and Takeshi Iwasa : Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia, The Journal of Obstetrics and Gynaecology Research, Vol.50, No.4, 633-638, 2024. (Summary) Medroxyprogesterone acetate (MPA) is one of the treatments of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) to preserve the fertility. Efficacy of MPA therapy and fertility and obstetric outcomes after remission were evaluated in EC or AEH patients. Among patients diagnosed with EC or AEH at Tokushima University Hospital between January 2002 and October 2020, we retrospectively analyzed patients, ages range from 26 to 40, who underwent conservative management using MPA (400-600 mg/day). In total, 19 patients underwent MPA therapy. The 18 (94%) patients achieved complete response (CR), and 1 (5%) patient achieved partial response (PR). Relapse occurred in 6 (32%) patients who had achieved CR. Of the patients who relapsed, 4 patients resumed MPA therapy and were in remission. Among 19 patients, 13 patients attempted pregnancy after CR. All of them underwent ovulation induction or assisted reproductive technology. As a result, 20 pregnancies in 10 (77%) patients and 12 live births in 9 (69%) patients were achieved. Rate of spontaneous abortion was 35% (7/20). MPA therapy can produce a high remission rate, and be considered an effective treatment for patients who wish fertility preservation. Around 70% patients who attempt to pregnancy can have at least one baby by infertility treatments. Because recurrence rate after MPA therapy is high, it may be desirable to aim for early pregnancy by active intervention. (Keyword) Pregnancy / Humans / Female / Medroxyprogesterone Acetate / Endometrial Hyperplasia / Retrospective Studies / Antineoplastic Agents, Hormonal / Neoplasm Recurrence, Local / Endometrial Neoplasms / Fertility Preservation / Treatment Outcome / Pathologic Complete Response (Link to Publication Site) ● Publication site (DOI): 10.1111/jog.15872 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38154145 ● Search Scopus @ Elsevier (PMID): 38154145 ● Search Scopus @ Elsevier (DOI): 10.1111/jog.15872 (DOI: 10.1111/jog.15872, PubMed: 38154145)
8.	Maimi Uchishiba, Shota Yamamoto, Asuka Takeda, Ryosuke Arakaki, Moeka Arata, Hiroki Noguchi, Hidenori Aoki, Kou Tamura, Takaaki Maeda, Saki Minato, Mari Nii, Hiroaki Inui, Shuhei Kamada, Riyo Kinouchi, Yuri Yamamoto, Kanako Yoshida, Shigetaka Yagi, Takeshi Katou, Takashi Kaji, Masato Nishimura, Kazuhiko Ino and Takeshi Iwasa : Progesterone treatment reduces food intake and body weight in ovariectomized female rats, Steroids, Vol.203, 109367, 2024. (Summary) While the effects of progesterone on body weight and appetite in pre-menopausal conditions have been well elucidated, its effects in post-menopausal conditions have not been clarified. On the contrary, the effects of estrogen on body weight and appetite in post-menopausal conditions have been well established. In this study, the effects of progesterone treatment on body weight, appetite, and fat mass in ovariectomized rats were evaluated. In addition, the central and/or peripheral levels of oxytocin (OT), leptin, and their receptors, which are potent anorectic factors, were examined. Female rats were ovariectomized and divided into control, progesterone-treated, and estrogen-treated groups. Body weight, food intake, and subcutaneous fat mass were lower in both the progesterone and estrogen groups than in the control group. The estrogen group exhibited higher serum OT levels than the control group, whereas the OT levels of the progesterone and control groups did not differ. The serum leptin levels of both the progesterone and estrogen groups were lower than those of the control group. Gene expression analysis of OT, leptin, and their receptors in the hypothalamus and adipose tissue found few significant differences among the groups. Hypothalamic neuropeptide Y (NPY) and pro-opiomelanocortin (POMC) mRNA levels involved in appetite regulation were slightly altered in the progesterone and estrogen groups. These findings suggest that progesterone treatment may have favorable effects on body weight, appetite, and fat mass regulation in post-menopausal conditions and that the mechanisms underlying these effects of progesterone differ from those underlying the effects of estrogen. (Keyword) Animals / Female / Rats / Body Weight / Carrier Proteins / Eating / Estrogens / Hypothalamus / Leptin / Pro-Opiomelanocortin / Progesterone (Link to Publication Site) ● Publication site (DOI): 10.1016/j.steroids.2024.109367 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38266463 ● Search Scopus @ Elsevier (PMID): 38266463 ● Search Scopus @ Elsevier (DOI): 10.1016/j.steroids.2024.109367 (DOI: 10.1016/j.steroids.2024.109367, PubMed: 38266463)
9.	山中絵里加, Yuri Yamamoto, Hiroki Noguchi, Kou Tamura, AOKI Hidenori, Asuka Takeda, Ryosuke Arakaki, Maimi Uchishiba, Saki Minato, Shuhei Kamada, Riyo Kinouchi and Takeshi Iwasa : 当院におけるAYA世代の妊孕性温存症例の治療背景とその転帰, Modern Trends in Obstetrics & Gynecology, Vol.73, No.1, 53-57, 2024.
10.	内芝舞実, Yuri Yamamoto, 宮本容子, 吉田友紀子, Hiroki Noguchi, Asuka Takeda, Saki Minato, 鎌田周平, 白河綾, Eishi Sogawa, Ayuka Mineda, Atsuko Yoshida, Takashi Kaji, 苛原稔 and Takeshi Iwasa : 当院におけるART妊娠者でのNIPT受検率について, 徳島産婦人科医報, No.56, 3-7, 2023.
11.	Kei Daizumoto, Saki Minato, 小居浩之, Tomoteru Kishimoto, Takeshi Iwasa, Masayuki Takahashi and Hiro-omi Kanayama : 徳島大学病院における不妊治療の取り組み, The Nishinihon Journal of Urology, Vol.85, 317-323, 2023.
12.	Saki Minato, Yuri Yamamoto, 野口拓樹, Maimi Uchishiba, Shuhei Kamada, 谷口友香, 河北貴子, Minoru Irahara and Takeshi Iwasa : 当院における精巣内精子採取術・顕微授精(testicular sperm extraction-intracytoplasmic sperm injection: TESE-ICSI)の治療成績と周産期予後の検討, Modern Trends in Obstetrics & Gynecology, Vol.71, No.1, 93-98, 2022. (Keyword) TESE / ICSI / perinatal prognosis (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520857757594822656 (CiNii: 1520857757594822656)
13.	Shuhei Kamada, Yuri Yamamoto, Hidenori Aoki, Kou Tamura, Asuka Takeda, Saki Minato, Rie Masaki, Rie Yanagihara, Noriko Hayashi, Yuya Yano, Junki Imaizumi, Tomohiro Kagawa, Atsuko Yoshida, Takako Kawakita, Minoru Irahara and Takeshi Iwasa : A novel PCOS rat model and an evaluation of its reproductive, metabolic, and behavioral phenotypes., Reproductive Medicine and Biology, Vol.21, No.1, e12416, 2021. (Summary) Although animal models of PCOS have been used in many studies, none of them can reproduce both the reproductive and metabolic phenotypes of PCOS. In addition, behavioral parameters have not been evaluated in PCOS animal models. We tried to produce an improved rat model of PCOS, and the reproductive, metabolic, and behavioral phenotypes of the model rats were evaluated. Female rats were implanted with silicon tubes containing oil-dissolved dihydrotestosterone (Oil-DHT) as a new PCOS model. Their phenotypes were compared with those of conventional PCOS model rats (DHT), into which tubes containing crystalline DHT were implanted, and non-DHT-treated rats (control). Both the Oil-DHT and DHT rats showed greater body weight gain, food intake, and fat depot weight than the control rats. Furthermore, these groups showed fewer estrous stages and increased numbers of cystic follicles. The DHT rats exhibited lower ovarian and uterine weights than the control rats, whereas no such changes were observed in the Oil-DHT rats. The Oil-DHT and DHT rats showed less locomotor activity in the light phase than the control rats. Our proposed PCOS model reproduced both the reproductive and metabolic phenotypes of PCOS and may have potential for PCOS research. (Tokushima University Institutional Repository) ● Metadata: 2010509 (Link to Publication Site) ● Publication site (DOI): 10.1002/rmb2.12416 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34934399 ● Search Scopus @ Elsevier (PMID): 34934399 ● Search Scopus @ Elsevier (DOI): 10.1002/rmb2.12416 (Tokushima University Institutional Repository: 2010509, DOI: 10.1002/rmb2.12416, PubMed: 34934399)

Academic Paper (Unrefereed Paper):

1.	Asuka Takeda, Yuri Yamamoto, Kou Tamura, H. Aoki, Hiroki Noguchi, Saki Minato, Shuhei Kamada, Ryosuke Arakaki, Takashi Kaji and Takeshi Iwasa : Retraction: Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents (Human Vaccines & Immunotherapeutics, (2017), 13, 10, (2332-2340), 10.1111/jog.16113), The Journal of Obstetrics and Gynaecology Research, Vol.50, No.11, 2164, 2024. (Summary) A. Takeda , Y. Yamamoto , K. Tamura , H. Aoki , H. Noguchi , S. Minato , S. Kamada , R. Arakaki , T. Kaji , and T. Iwasa , "Oncologic, Fertility, and Obstetric Outcomes With MPA Therapy in Women with Endometrial Cancer and Atypical Endometrial Hyperplasia," The Journal of Obstetrics and Gynaecology Research 50, no. 4 (2024): 633-638, https://doi.org/10.1111/jog.15872. The above article, published online on 28 December 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Hiroaki Kajiyama; and John Wiley & Sons, Australia, Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed major conceptual overlap and significant primary data redundancy with a previously published article by an overlapping group of authors. Such publishing practice is against the journal's policy and Wiley's Best Practice Guidelines on Research Integrity and Publishing Ethics. (Link to Publication Site) ● Publication site (DOI): 10.1111/jog.16113 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 39353716 ● Summary page in Scopus @ Elsevier: 2-s2.0-85205305710 (DOI: 10.1111/jog.16113, PubMed: 39353716, Elsevier: Scopus)
2.	Takeshi Iwasa, Hiroki Noguchi, Risa Tanano, Erika Yamanaka, Asuka Takeda, Kou Tamura, Hidenori Aoki, Tatsuro Sugimoto, Hikari Sasada, Takaaki Maeda, Saki Minato, Shota Yamamoto, Hiroaki Inui, Tomohiro Kagawa, Atsuko Yoshida, Ayuka Mineda, Mari Nii, Riyo Kinouchi, Kanako Yoshida, Yuri Yamamoto and Takashi Kaji : Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals., International Journal of Molecular Sciences, Vol.24, No.23, 16567, 2023. (Summary) In recent years, the effects of androgens on metabolic and body weight regulation systems and their underlying mechanisms have been gradually revealed in females. In women and experimental animals of reproductive age, androgen excess can adversely affect metabolic functioning, appetite, and body weight regulation. In addition, excess androgens can increase the risk of metabolic disorders, such as obesity, insulin resistance, and diabetes. These unfavorable effects of androgens are induced by alterations in the actions of hypothalamic appetite-regulatory factors, reductions in energy expenditure, insulin resistance in skeletal muscle, and β-cell dysfunction. Interestingly, these unfavorable effects of androgens on metabolic and body-weight regulation systems are neither observed nor evident in ovariectomized animals and post-menopausal women, indicating that the adverse effects of androgens might be dependent on the estrogen milieu. Recent findings may provide novel sex- and age-specific strategies for treating metabolic diseases. (Keyword) Animals / Humans / female / Androgens / Insulin Resistance / Obesity / Metabolic Diseases / Animals, Laboratory / Polycystic Ovary Syndrome (Tokushima University Institutional Repository) ● Metadata: 2000318 (Link to Publication Site) ● Publication site (DOI): 10.3390/ijms242316567 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38068890 ● Search Scopus @ Elsevier (PMID): 38068890 ● Search Scopus @ Elsevier (DOI): 10.3390/ijms242316567 (Tokushima University Institutional Repository: 2000318, DOI: 10.3390/ijms242316567, PubMed: 38068890)
3.	松崎利也, Takeshi Iwasa, 岩瀬明, 金崎春彦, 久具宏司, 斎藤和毅, 馬場剛, 原鐵晃 and Saki Minato : 本邦における多囊胞性卵巣症候群の診断基準の検証に関する小委員会, Acta Obstetrica et Gynaecologica Japonica, Vol.74, No.6, 681-685, 2022.
4.	Kou Tamura, Yuri Yamamoto, Saki Minato, 柳原里江, Shuhei Kamada, 谷口友香, 阿部彰子, Masato Nishimura, Minoru Irahara and Takeshi Iwasa : 子宮内膜癌・子宮内膜異型増殖症に対する妊孕性温存治療の治療効果と妊娠成績，周産期予後, Modern Trends in Obstetrics & Gynecology, Vol.70, No.1, 123-128, 2021. (Keyword) 子宮内膜癌 / 子宮内膜異型増殖症 / MPA療法 / 妊孕性温存 / endometrial cancer / atypical endometrial hyperplasia / medroxyprogesterone acetate (MPA) treatment / シキュウナイマクガン / シキュウナイマクイケイゾウショクショウ / MPA リョウホウ / ニンヨウセイオンゾン (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520853835559930496 (CiNii: 1520853835559930496)

Review, Commentary:

1.	Takeshi Iwasa, Hiroki Noguchi and Saki Minato : 特集婦人科外来診療レベルアップ-病状の評価分類と治療指針- 4.排卵障害分類(HyPO-P)と治療指針, Obstet. Gynecol. (tokyo), Vol.90, No.12, 1321-1324, Dec. 2023. (Link to Publication Site) ● Publication site (DOI): 10.34433/og.0000000476 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390861161891942144 ● Search Scopus @ Elsevier (DOI): 10.34433/og.0000000476 (DOI: 10.34433/og.0000000476, CiNii: 1390861161891942144)
2.	Takeshi Iwasa, Hiroki Noguchi and Saki Minato : 特集多囊胞性卵巣症候群UPDATE--病態を理解しライフステージに応じた管理を考える診断基準の考え方, Journal of Clinical and Experimental Medicine, Vol.286, No.11, 883-886, Sep. 2023. (Link to Publication Site) ● Publication site (DOI): 10.32118/ayu28611883 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390862643867252352 ● Search Scopus @ Elsevier (DOI): 10.32118/ayu28611883 (DOI: 10.32118/ayu28611883, CiNii: 1390862643867252352)
3.	Takeshi Iwasa and Saki Minato : 特集生殖医療の保険適用の実際Ⅱ 各論生殖医療で用いられる技術の先進医療への申請と課題, Obstetrical and Gynecological Practice, Vol.72, No.6, 569-573, Jun. 2023. (Link to Publication Site) ● Publication site (DOI): 10.18888/sp.0000002575 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390296508836620032 ● Search Scopus @ Elsevier (DOI): 10.18888/sp.0000002575 (DOI: 10.18888/sp.0000002575, CiNii: 1390296508836620032)
4.	松崎利也, 野口拓樹, Saki Minato and Takeshi Iwasa : インスリン抵抗性改善薬(メトホルミン), The Journal of Practical Pharmacy, Vol.73, No.10, 81-87, Sep. 2022. (Link to Publication Site) ● Publication site (DOI): 10.15104/j01461.2022302081 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390294960529874176 ● Search Scopus @ Elsevier (DOI): 10.15104/j01461.2022302081 (DOI: 10.15104/j01461.2022302081, CiNii: 1390294960529874176)
5.	Shuhei Kamada, Saki Minato and Takeshi Iwasa : 多囊胞性卵巣症候群の診断と課題, Obstetrical and Gynecological Practice, Vol.71, No.9, 921-926, Sep. 2022.
6.	松崎利也, Saki Minato and Takeshi Iwasa : 多囊胞性卵巣症候群の診断と治療, Clinical Gynecology and Obstetrics, Vol.76, No.4, 228-232, Apr. 2022. (Link to Publication Site) ● Publication site (DOI): 10.11477/mf.1409210677 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390291932641996032 ● Search Scopus @ Elsevier (DOI): 10.11477/mf.1409210677 (DOI: 10.11477/mf.1409210677, CiNii: 1390291932641996032)
7.	Takeshi Iwasa, Saki Minato and Yuri Yamamoto : 新鮮胚移植と凍結胚移植の安全性, Clinical Gynecology and Obstetrics, Vol.76, No.4, 122-125, Apr. 2022. (Link to Publication Site) ● Publication site (DOI): 10.11477/mf.1409210652 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390010457642203648 ● Search Scopus @ Elsevier (DOI): 10.11477/mf.1409210652 (DOI: 10.11477/mf.1409210652, CiNii: 1390010457642203648)

Proceeding of Domestic Conference:

1.	Takeshi Iwasa, Hiroki Noguchi and Saki Minato : シンポジウム:多囊胞性卵巣症候群の病態，診断，治療, 第44回日本肥満学会・第41回日本肥満症治療学会学術集会, Nov. 2023.

Report:

1.	松崎利也, Takeshi Iwasa, 岩瀬明, 金崎春彦, 久具宏司, 木村文則, 齋藤和毅, 馬場剛, 原鐡晃, Hiroki Noguchi and Saki Minato : 本邦における多囊胞性卵巣症候群の診断基準の検証に関する小委員会, Acta Obstetrica et Gynaecologica Japonica, Vol.75, No.6, Jun. 2023.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Search by Researcher Number (40991477)